Fang Deng

Fang Deng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Stem Cell Reviews and Reports
Verified
Journal Article
Open access
PDF file
HGHaiyan Guo
Haiyan Guo
YSYue Su
Yue Su
FDFang Deng
Fang Deng
Mesenchymal stromal cells (MSCs) as a kind of pluripotent adult stem cell have shown great therapeutic potential in relation to many diseases in anti-inflammation and regeneration. The results of preclinical experiments and clinical trials have demonstrated that MSC-derived secretome possesses immunoregulatory and reparative abilities and that this secretome is capable of modulating innate and adaptive immunity and reprograming the metabolism of recipient cells via paracrine mechanisms. It has been recognized that MSC-derived secretome, including soluble proteins (cytokines, chemokines, growth factors, proteases), extracellular vesicles (EVs) and organelles, plays a key role in tissue repair and regeneration in bronchopulmonary dysplasia, acute respiratory distress syndrome (ARDS), bronchial asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension, and silicosis. This review summarizes the known functions of MSC-EV modulation in lung diseases, coupled with the future challenges of MSC-EVs as a new pharmaceutical agent. The identification of underlying mechanisms for MSC-EV might provide a new direction for MSC-centered treatment in lung diseases.Graphical abstract

17 January 2022 in Archives of Medical Science
Verified
Journal Article
Open access
LWLi Wang
Li Wang
JZJialiang Zhu
Jialiang Zhu
MXMingyun Xia
Mingyun Xia
RHRan Hua
Ran Hua
FDFang Deng
Fang Deng
Introduction: Frequently-relapsing/steroid-dependent nephrotic syndrome (FRSDNS) leads to steroid toxicity impairing quality of life (QOL), thus prompting the use of steroid-sparing drugs. Methods: 51 FRSDNS children not previously treated with steroid-sparing agents were randomized to...

6 September 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
KZKeran Zhu
Keran Zhu
HGHui Gao
Hui Gao
LYLiping Yuan
Liping Yuan
LWLili Wang
Lili Wang
FDFang Deng
Fang Deng
Objectives: We aimed to identify the factors associated with necrotizing enterocolitis (NEC) and to assess the associations of the initial empirical antibiotic therapy (IEAT) duration and antibiotic therapy duration/hospital stay ratio (A/H ratio) before NEC with subsequent NEC in very low birth weight (VLBW) infants with gestational age less than 32 weeks without proven sepsis.Methods: A retrospective study was conducted at the NICU of the First Affiliated Hospital of Medical University of Anhui province from June 2015 to May 2022, and 567 VLBW infants with gestational age less than 32 weeks were included in the study. We divided the VLBW infants into those with and without NEC according to modified Bell’s criteria. We then used descriptive statistics to identify the factors associated with NEC and multivariate analyses to evaluate the associations of IEAT duration and A/H ratio with the occurrence of NEC.Results: Of the 567 VLBW neonates admitted to our center, 547 survived and reached the normal discharge criteria. Fifty-one infants (8.99%) were diagnosed as showing NEC. Infants with NEC had a longer total parenteral nutrition time, total enteral nutrition time, and IEAT duration, as well as a higher A/H ratio than those without NEC. In multivariate analyses adjusted for the other factors, IEAT duration was associated with an increased odds of NEC [odds ratio (OR) = 1.267; 95% confidence interval (CI), 1.128–1.423], and the A/H ratio was also associated with increased odds of NEC (OR = 8.718; 95% CI, 2.450–31.030). For the A/H ratio, the area under the curve (AUC) was 0.767 and the ideal cutoff was 0.357, and the sensitivity and specificity were 0.843 and 0.645, respectively.Conclusion: Prolonged antibiotic therapy may increase the risk of NEC in VLBW infants with a gestational age of fewer than 32 weeks and should be used with caution.

29 October 2022 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
XGXianwei Guo
Xianwei Guo
YKYujie Ke
Yujie Ke
BWBirong Wu
Birong Wu
QSQiuxia Song
Qiuxia Song
CSChenyu Sun
Chenyu Sun
FDFang Deng
Fang Deng

10 June 2022 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
YXYuan-Yuan Xu
Yuan-Yuan Xu
CXCheng-Zhu Xu
Cheng-Zhu Xu
YLYou-Feng Liang
You-Feng Liang
DJDan-Qun Jin
Dan-Qun Jin
JDJie Ding
Jie Ding
FDFang Deng
Fang Deng
The current study aimed to investigate the effect of the combination of ascorbic acid (AscA) and hydrocortisone (Hyd) on septic organ injury and its potential mechanism.Sepsis was induced in mice b...

2 February 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
RKRuijuan Ke
Ruijuan Ke
YZYing Zhu
Ying Zhu
FDFang Deng
Fang Deng
DXDaliang Xu
Daliang Xu
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare genetic disease characterized by multiple immune disorders. Different mutations of the FOXP3 gene may lead to distinct clinical manifestations. Here, we present a rare case of IPEX syndrome caused by a novel variant of FOXP3. Clinical manifestations include autoimmune hemolysis, bronchiectasis, diarrhea, and proteinuria but without diabetes or other endocrine disorders. The diagnosis of IPEX syndrome was confirmed by whole-exon sequencing. Supportive treatment did not ameliorate the patient’s symptoms, while immunosuppressive therapy showed a promising efficacy. The patient we reported will improve the understanding of renal manifestations in IPEX syndrome.